Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
2341–2376
Headlines
2965
Sources here
21
Companies here
17
Current section United States Medical Instruments & Supplies news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

How Investors Are Reacting To Teleflex (TFX) Winning Premier Deal For Vascular Access Products

Teleflex Incorporated has secured a national group purchasing agreement with Premier, Inc. for its Arrow brand vascular access portfolio, which could expand its presence in hospital systems. This deal, along with the recent BIOTRONIK Vascular Intervention acquisition, emphasizes Teleflex's focus on vascular access and …

TFX main company
Sharemaestro market context Trend signal active 52 weeks +6.9% · Next-week setup negative 43.9% TFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Reminds Embecta Corp. (EMBC) Investors Seeking Recovery of the Lead Plaintiff Deadline on August 17, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against Embecta Corp. (EMBC) following disappointing Q2 fiscal 2026 results and a significant stock price drop. Investors who purchased Embecta securities between November 25, 2025, and May 4, 2026, are encouraged to join …

EMBC main company
Sharemaestro market context New activity signal 52 weeks -63.1% EMBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit

The Rosen Law Firm is reminding purchasers of Embecta Corp. common stock (NASDAQ: EMBC) between November 25, 2025, and May 4, 2026, of the August 17, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Embecta made misleading statements regarding …

EMBC main company
Sharemaestro market context New activity signal 52 weeks -63.1% EMBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to sales forward of Nyxoah SA – EURONEXT:NYXH

This article provides a financial data point for Nyxoah SA (EURONEXT:NYXH), specifically its forward price-to-sales ratio. It appears to be a stub or a data entry within a larger financial information platform like TradingView, with no further analytical content. The article primarily lists navigational …

NYXH main company
Sharemaestro market context Price below Trend Line 52 weeks -74.8% · Next-week setup negative 43.6% NYXH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?

This article compares Intuitive Surgical (ISRG) and Abbott Laboratories (ABT), two MedTech giants, to determine which is the smarter investment. While both companies have seen stock declines in 2026, they continue to perform well in their respective core businesses. The analysis suggests that ISRG, …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Enterprise value to revenue forward of Alcon AG – SIX:ALC

This page from TradingView provides financial information for Alcon AG (SIX:ALC), specifically focusing on its enterprise value to revenue forward metric. The content highlights the company's financials, offering data and metrics for investors and analysts interested in Alcon AG's performance. The page also indicates …

ALC main company
Sharemaestro market context Price above Trend Line 52 weeks -8.4% ALC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Reasons to Retain Align Technology Stock in Your Portfolio for Now

Align Technology (ALGN) is expected to see significant growth due to international expansion and advancements in its iTero intraoral scanning technology. Despite potential headwinds from a dull macroeconomic environment and unfavorable foreign exchange movements affecting sales, the company's geographic expansion in EMEA and APAC, …

ALGN main company
Sharemaestro market context Price above Trend Line 52 weeks +21.2% ALGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teleflex Inc. stock underperforms Thursday when compared to competitors

Teleflex Inc. (TFX) shares dropped by 2.70% on Thursday, closing at $131.16, in a trading session where both the S&P 500 and Dow Jones Industrial Average also experienced declines. This marks the second consecutive day of losses for the stock. Despite the broad market …

TFX main company
Sharemaestro market context Trend signal active 52 weeks +6.9% · Next-week setup negative 43.9% TFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Anteris Technologies Files Appendix 3G for New Share Issue

Anteris Technologies Global Corp. has filed an Appendix 3G for the issue of 500 new unquoted common shares dated July 22, 2026. This modest share issuance expands the company's equity base and is considered routine capital management, ensuring transparency for investors and regulators. The …

AVR main company
Sharemaestro market context Trend signal active 52 weeks +126.5% AVR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal

BioLife Solutions, a Bothell, Wash.-based company specializing in tools for cell and gene therapy, is set to be acquired by Repligen, a life sciences corporation, for $1.5 billion. The deal involves BioLife shareholders receiving $11.25 in cash plus 0.1442 shares of Repligen stock per …

BLFS main company
Sharemaestro market context Trend signal active 52 weeks +35.4% BLFS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharma says sterile packaging upgrades fuel demand for high-value plastics

West Pharmaceutical Services indicates that new European Union regulations regarding materials and sterile packaging are increasing the demand for high-value plastics. This surge in interest is particularly noted in the pharmaceutical packaging sector. The article highlights how these regulatory changes are influencing material choices …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICU Medical schedules Q2 2026 earnings call for August 6

ICU Medical Inc. (NASDAQ: ICUI) has announced that its second-quarter 2026 earnings will be released on Thursday, August 6, 2026, at approximately 4:00 p.m. ET. A conference call to discuss these results will follow at 4:30 p.m. ET. Investors can access the call via …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Repligen to Expand Cell Therapy Capabilities With BioLife Buyout

Repligen Corporation announced an agreement to acquire BioLife Solutions for approximately $1.5 billion, aiming to strengthen its position in the rapidly growing cell therapy market. This acquisition is expected to complement Repligen's existing solutions, add a high-margin consumables business, and be accretive to revenue …

RGEN main company BLFS mentioned
Sharemaestro market context Trend signal active 52 weeks +33.7% RGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Press Release: Teleflex Announces Second Quarter 2026 Earnings Conference Call Information

Teleflex (NYSE: TFX) will announce its financial results for the second quarter of 2026 before the market opens on Thursday, August 1, 2026. The company will host a conference call at 8:00 a.m. ET

TFX main company
Sharemaestro market context Trend signal active 52 weeks +6.9% · Next-week setup negative 43.9% TFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants

This Zacks Analyst Blog highlights research reports on several key stocks, including Qualcomm Inc. (QCOM), Intuitive Surgical, Inc. (ISRG), Stryker Corp. (SYK), Frequency Electronics, Inc. (FEIM), and Good Times Restaurants Inc. (GTIM). The report provides an overview of each company's recent performance, challenges, and …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AptarGroup (ATR) Expected to Beat Earnings Estimates: Should You Buy?

Wall Street expects a year-over-year decline in earnings on higher revenues when AptarGroup (ATR) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock …

ATR main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% ATR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline

The market expects Baxter International (BAX) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …

BAX main company
Sharemaestro market context Trend signal active 52 weeks +9.8% BAX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharma raises profit forecast on strong demand for injectable drug components

West Pharmaceutical Services has raised its annual profit forecast, driven by robust demand for its components used in injectable drugs. The company reported strong Q2 adjusted earnings and net sales, exceeding analyst estimates. These positive results prompted West Pharma to boost its full-year 2026 …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Garrison to retire from BD at end of fiscal year

Dr. Michael “Mike” Garrison, executive vice president and president of the Medical Essentials and BioPharma Systems segments at BD (Becton, Dickinson and Company), is retiring after more than 20 years with the company, effective October 2. During his tenure, Garrison held several leadership roles …

BDX main company
Sharemaestro market context Price above Trend Line 52 weeks +19.7% · Next-week setup negative 33.9% BDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharmaceutical (WST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, West Pharmaceutical Services (WST) reported revenue of $872.3 million, up 13.8% over the same period last year. EPS came in at $2.37, compared to $1.84 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AtriCure set to report earnings as competitive threat looms

AtriCure Inc. is preparing to report its second-quarter earnings, with analysts expecting an adjusted loss on strong revenue growth. The company faces new competition in the surgical left atrial appendage closure market from Edwards Lifesciences, but analysts believe AtriCure's established position and diverse product …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EMBC INVESTOR ALERT: Embecta Corp. (EMBC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS

Hagens Berman is investigating Embecta Corp. (EMBC) following a class action lawsuit alleging the company misrepresented the stability of its insulin pen needle business, leading to substantial investor losses. The lawsuit claims Embecta misled investors about its "stable" business despite experiencing significant competitive share …

EMBC main company
Sharemaestro market context New activity signal 52 weeks -63.1% EMBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: West Pharmaceutical beats Q2 2026 estimates, lifts outlook

West Pharmaceutical Services (WST) reported stronger-than-expected Q2 2026 results, with adjusted EPS up 29% to $2.37 and revenue climbing 13.8% to $872.3 million, both beating analyst estimates. The company raised its full-year guidance for sales and profit, driven by strong demand in biologics, GLP-1 …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why is West Pharmaceutical Services stock surging today?

West Pharmaceutical Services Inc. stock surged 6.1% in pre-open trading after reporting second-quarter 2026 results that significantly beat Wall Street expectations for both earnings and revenue. The company also raised its full-year 2026 adjusted EPS guidance, signaling strong momentum in high-value injectable drug

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call

ICU Medical, Inc. (Nasdaq: ICUI) announced the schedule for its second quarter 2026 earnings release and conference call. The company will release its results on Thursday, August 6, 2026, at approximately 4:00 p.m. ET, with the conference call to follow at 4:30 p.m. ET. …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ICU Medical Sets Aug. 6 Date for Second-Quarter Results

ICU Medical (Nasdaq: ICUI) announced its second-quarter 2026 financial results will be released on Thursday, August 6, 2026, at approximately 4:00 p.m. ET. This will be followed by an earnings conference call at 4:30 p.m. ET, accessible via phone and webcast. Historically, similar announcements …

ICUI main company
Sharemaestro market context Trend signal active 52 weeks +42.8% ICUI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharmaceutical Services Releases Q2 2026 Financial Results

West Pharmaceutical Services (WST) reported strong Q2 2026 financial results, with adjusted EPS of $2.37, beating estimates by 13.9%, and revenue of $872.3 million, exceeding expectations by 3.8%. The company saw significant growth in its Proprietary Products segment and maintains a positive outlook for …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Utah Medical expects zero 2026 sales from two former customers; 10%-13% drop

Utah Medical Products (UTMD) announced significant declines in Q2 and 1H 2026 revenues, down 14.3% and 12.3% respectively, primarily due to zero sales to its two previously largest customers. The company now projects a 10-13% decline in 2026 sales compared to 2025, as efforts …

UTMD main company
Sharemaestro market context Trend signal active 52 weeks +18.8% UTMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Canaccord reiterates Hold on Repligen stock after BioLife deal

Canaccord Genuity has reiterated a Hold rating on Repligen Corp. with a $145.00 price target following Repligen's acquisition of BioLife Solutions for approximately $1.5 billion. While the acquisition is expected to be accretive to Repligen's financials and expand its presence in new modalities, Canaccord …

RGEN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% RGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intuitive Shares Vision for an AI-Enabled Future of Healthcare

Intuitive (NASDAQ: ISRG) has outlined its vision for an AI-enabled future of surgical care, proposing a five-layer AI framework to address healthcare challenges such as improving outcomes, lowering costs, and expanding access. The company also demonstrated real-time telesurgical collaboration between California and Georgia, highlighting …

ISRG main company
Sharemaestro market context Price below Trend Line 52 weeks -17.1% · Next-week setup negative 41.3% ISRG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

West Pharmaceutical Services (NYSE:WST) reported strong Q2 CY2026 results, exceeding revenue and adjusted EPS expectations. The company saw a 13.8% year-on-year revenue increase to $872.3 million and an adjusted EPS of $2.37, beating analyst estimates by 13.9%. Following the positive report, the company also …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AVTR: Avantor Inc. Latest Stock Price, Analysis, News and Trading Ideas

This article provides a brief overview of Avantor Inc. (AVTR), including its current stock price, market capitalization, key financial metrics, and upcoming earnings date. It also highlights recent news related to AVTR's expected earnings and includes trending discussions about other stocks.

AVTR main company
Sharemaestro market context Trend signal active 52 weeks +2.9% AVTR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Teleflex to host Q2 2026 earnings conference call on August 6

Teleflex Incorporated will host a conference call on August 6, 2026, at 8:00 a.m. Eastern Time to discuss its second-quarter 2026 financial results and provide operational updates. Investors and interested parties can access the live audio webcast through the company's website or pre-register for …

TFX main company
Sharemaestro market context Trend signal active 52 weeks +6.9% · Next-week setup negative 43.9% TFX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8-K WEST PHARMACEUTICAL SERV For: Jul 23

West Pharmaceutical Services, Inc. filed a Form 8-K on July 23, 2026, to announce its second-quarter 2026 financial results. The report includes a press release (Exhibit 99.1) and presentation materials (Exhibit 99.2) related to these results. The company also confirmed its registration with the …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

West Pharmaceutical Services (WST) Q2 Earnings and Revenues Top Estimates

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $2.08 per share. This compares to earnings of $1.84 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

WST main company
Sharemaestro market context Trend signal active 52 weeks +41.3% · Next-week setup positive 56.7% WST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context